APA (7th ed.) Citation

Cao, F., & Yin, L. (2019). miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Experimental and molecular pathology, 106, 34-43. https://doi.org/10.1016/j.yexmp.2018.10.009

Chicago Style (17th ed.) Citation

Cao, Fei, and Li-Xue Yin. "MiR-122 Enhances Sensitivity of Hepatocellular Carcinoma to Oxaliplatin via Inhibiting MDR1 by Targeting Wnt/β-catenin Pathway." Experimental and Molecular Pathology 106 (2019): 34-43. https://doi.org/10.1016/j.yexmp.2018.10.009.

MLA (9th ed.) Citation

Cao, Fei, and Li-Xue Yin. "MiR-122 Enhances Sensitivity of Hepatocellular Carcinoma to Oxaliplatin via Inhibiting MDR1 by Targeting Wnt/β-catenin Pathway." Experimental and Molecular Pathology, vol. 106, 2019, pp. 34-43, https://doi.org/10.1016/j.yexmp.2018.10.009.